Blocknomi
Key Highlights JPMorgan increased Eli Lilly’s price target to $1,400 from $1,300 while reaffirming an Overweight rating RBC Capital pushed its target to $1,500 from $1,250, keeping an Outperform rating…
Related articles
-
OKX Announces Direct Crypto Aid for Venezuelans Hit by Devastating Twin Earthquakes
Bitcoin.com Published 03.07.2026 19:52
-
Ethereum’s Government Pitch: Why Public-Sector Blockchains Need Governance Before Hype
Crypto Daily Published 02.07.2026 18:11
-
Kraken eyes 15% stake in Aave at $385 million valuation
Crypto.News Published 26.06.2026 07:55
-
Institutions in Japan Turn to Bitcoin and XRP as SBI VC Trade Hits 2M Registered Accounts
The Crypto Basic Published 08.07.2026 07:11
-
Bought ETH in Past 5 Years? You Are Now Net Negative
U.Today Published 30.06.2026 08:18
-
CLARITY Act faces Aug. 7 deadline after July 4 target slips
Crypto.News Published 06.07.2026 06:42
-
BIT Takes on Stock Brokerages with Margin Trading for US Equities and $2,000 Cashback
BlockchainReporter Published 27.06.2026 12:15
-
Zalando Shares Fall 7% After BaFin Launches Accounting Probe
BeInCrypto Published 26.06.2026 13:55